Across TCGA pan-cancer cohorts, MIR147A RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MIR147A data layer compared with 1 for mutation status.
The strongest signal is observed in glioblastoma multiforme (GBM), where higher MIR147A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR147A expression acts as an unfavorable survival marker, although some lineages such as MESO show a favorable association.
GBM, KIRC, and OV are the cancer types where MIR147A RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.